Annovis Bio, Inc. 10-Q filing
Filed 2025-11-12 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001104659-25-110393
- Form type
- 10-Q
- CIK
- 0001477845
- Primary document
- https://www.sec.gov/Archives/edgar/data/1477845/000110465925110393/anvs-20250930x10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Annovis Bio, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $0 | - | - |
| Operating Income | $-20.0M | - | - |
| Net Income | $-19.0M | - | - |
| Eps Basic | -1.01 | - | - |
| Eps Diluted | -1.01 | - | - |
| Cash And Equivalents | $15.3M | - | - |
| Total Assets | $17.2M | - | - |
| Total Liabilities | $4.0M | - | - |
| Shareholders Equity | $13.2M | - | - |
| Operating Cash Flow | $-16.7M | - | - |